Last $7.50 USD
Change Today +0.23 / 3.16%
Volume 1.2M
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

pacific biosciences of calif (PACB) Snapshot

Open
$7.25
Previous Close
$7.27
Day High
$7.50
Day Low
$7.06
52 Week High
01/21/14 - $8.20
52 Week Low
04/15/14 - $3.87
Market Cap
535.2M
Average Volume 10 Days
580.4K
EPS TTM
$-0.94
Shares Outstanding
71.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PACIFIC BIOSCIENCES OF CALIF (PACB)

pacific biosciences of calif (PACB) Related Bloomberg News

View More Bloomberg News

pacific biosciences of calif (PACB) Related Businessweek News

View More BusinessWeek News

pacific biosciences of calif (PACB) Details

Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis in the deoxyribonucleic acid (DNA) sequencing market. The company is engaged in developing a single molecule real-time (SMRT) technology for the detection of biological processes. Its SMRT technology is used to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. The company’s product includes the PacBio RS II high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company’s customers include genome centers, genomics service providers, and pharmaceutical and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company, formerly known as Nanofluidics, Inc., was founded in 2000 and is headquartered in Menlo Park, California.

318 Employees
Last Reported Date: 03/14/14
Founded in 2000

pacific biosciences of calif (PACB) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: $1.0
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $1.0
Senior Vice President of Market Development
Total Annual Compensation: $361.5K
Senior Vice President of Research and Develop...
Total Annual Compensation: $361.5K
Compensation as of Fiscal Year 2013.

pacific biosciences of calif (PACB) Key Developments

Pacific Biosciences of California, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014

Pacific Biosciences of California, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 . Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Pacific Biosciences Mulls Acquisitions

Pacific Biosciences of California, Inc. (NasdaqGS:PACB) intends to pursue acquisitions. Pacific Biosciences has filed a Shelf Registration to raise $150 million. The company plans to use the net proceeds for general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

Suqian Lakeside Pangu Gene Company to Use PacBio Single Molecule, Real-Time (SMRT(R)) Sequencing

Pacific Biosciences of California, Inc. and Suqian Lakeside Pangu Gene Company announced that SLPC has established a new genomics facility with 1,500 square meters of laboratory space in the Tianjin Dong Li Lake Technology Park, dedicated to using PacBio Single Molecule, Real-Time (SMRT(R)) Sequencing as the major sequencing platform for its translational medicine research projects. SLPC purchased four PacBio RS II Sequencing Systems earlier this year and recently installed them at their newly dedicated facility. The company ultimately intends to focus on applications such as molecular-based approaches for early diagnosis of cancers, disease recurrence control and drug efficacy evaluation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PACB:US $7.50 USD +0.23

PACB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $4.68 USD 0.00
Fluidigm Corp $32.70 USD +1.69
Luminex Corp $18.46 USD +0.09
NanoString Technologies Inc $13.76 USD -0.73
Sequenom Inc $3.60 USD -0.04
View Industry Companies
 

Industry Analysis

PACB

Industry Average

Valuation PACB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.0x
Price/Book 10.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIFIC BIOSCIENCES OF CALIF, please visit www.pacificbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.